50 results
8-K
EX-99.1
nmh0d1g9npjfsj sg5le
12 Feb 24
Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update
4:00pm
8-K
EX-99.1
p06y4q9lu
9 Nov 23
Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update
6:44am
424B4
n6icpja2
2 Oct 23
Prospectus supplement with pricing info
5:05pm
8-K
EX-99.1
cbs727uj4uluwp6m9kr
5 Jun 23
Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria
8:32am
PRE 14A
x88xuy719q74r731mq
21 Apr 23
Preliminary proxy
4:00pm